People on HIV drugs have ‘substantial’ Alzheimer’s protection: study
May 12, 2025People taking drugs for HIV and hepatitis B are less likely to develop Alzheimer’s disease, according to a new study. UVA Health investigators now would like clinical trials to examine the potential of the HIV medications as a means to prevent Alzheimer’s disease.
AHEAD: Linkage to HIV Medical Care
April 8, 2023This page describes the Linkage to HIV Medical Care indicator data which informs the EHE AHEAD dashboard.
Altered gut microbiota correlates with different immune responses to HAART in HIV-infected individuals
January 6, 2021Gut microbiota and immune activation were studied in 36 non-HIV-infected subjects and 58 HIV-infected individuals, including 28 immunological responders and 30 immunological non-responders without comorbidities.
A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study
June 4, 2018A cross-sectional study assessed how effective it was for those on HIV meds to not transmit to others, along with how high the loss to follow-up was in various HIV programs. They found that there was a high loss of follow-up in HIV care programs, but it highlighted the need for intervention as well as an increase in rates of viral suppression.
